参考文献/References:
[1] ZHAO Hongwei, LIU Fuquan, YUE Zhendong, et
al. Association of hepatic vein Lipiodol tram-track
sign during transcatheter arterial chemoembolization
with perioperative death.[J]. J Int Med Res, 2017,
45(3):1148-1157.
[2] LEE, H S, KIM J S, CHOI I J, et al. The safety and efficacy
of transcatheter arterial chemoembolization in the
treatment of patients with hepatocellular carcinoma and
main portal vein obstruction. A prospective controlled
study[J]. Cancer, 1997,79(11):2087-2094.
[3] ADACHI E, MATSUMATA T, NISHIZAKI T, et al.
Effects of preoperative transcatheter hepatic arterial
chemoembolization for hepatocellular carcinoma. The
relationship between postoperative course and tumor
necrosis.[J]. Cancer, 1993,72(12):3593-3598.
[4] CORDELLA M, TABOLACCI C, ROSSI S, et al.
Transglutaminase type 2 affects cell migration through
post-translational modification of platelet-derived
growth factor-BB[J]. Amino Acids, 2017, 49(3):473-
481.
[5] MIZUTANI Y, OKADA Y, YOSHIDA O. Expression of
platelet-derived endothelial cell growth factor in bladder
carcinoma.[J]. Cancer, 1997, 79(6):1190-1194.
[6] LU Yi, LIN Nan, CHEN Zhiju, et al. Hypoxia-induced
secretion of platelet-derived growth factor-BB by hepatocellular
carcinoma cells increases activated hepatic
stellate cell proliferation, migration and expression of
vascular endothelial growth factor-A.[J]. Mol Med Rep,
2015, 11(1):691-697.
[7] 中国抗癌协会肝癌专业委员会，中国抗癌协会临
床肿瘤学协作专业委员会，中华医学会肝病学会
肝癌分组，全国肝胆肿瘤及移植病理协作组。
原发性肝癌规范化病理诊断方案专家共识[J]. 肝
脏,2011,16(3):244-246.
Chinese Societies of Liver Cancer and Clinical
Oncology, Chinese Anti-cancer Association, Liver
Cancer Study Group, Chinese Sociey of Hepatology,
Chinese Medical Association, Chinese Pathological
Group of Hepatobiliary Tumors and Liver Transplantation.
Experts consensus on pathological diagnosis
of primary liver cancer[J]. Chinese Hepatology,
2011,16(3):244-246.
[8] VINCENZI B, MAIO M, SILLETTA M, et al. Prognostic
relevance of objective response according to
EASL criteria and mRECIST criteria in hepatocellular
carcinoma patients treated with loco-regional therapies:
a literature-based meta-analysis[J]. PLoS One, 2015,
10(7):e0133488.
[9] GUAN Qinglong, GU Junpeng, ZHANG Haixiao, et al.
Correlation between vascular endothelial growth factor
levels and prognosis of hepatocellular carcinoma patients
receiving radiofrequency ablation[J]. Biotechnol
Biotechnol Equip, 2015, 29(1):119-123.
[10] ZHANG Wei, KIM R, QUINTINI C, et al. Prognostic
role of plasma vascular endothelial growth factor in
patients with hepatocellular carcinoma undergoing liver
transplantation[J]. Liver Transpl, 2015, 21(1):101-111.
[11] CHEN Jiaomei, LAI L, LIU S, et al. Targeting HIF-1α
and VEGF by lentivirus-mediated RNA interference reduces
liver tumor cells migration and invasion under hypoxic
conditions[J]. Neoplasma, 2016, 63(6):934-940.
[12] 凌耿强, 马东营, 何瑞星，等. 肿瘤细胞微环境对胶
质瘤血管生成拟态形成的影响[J]. 中国医药生物技
术, 2017, 12(2):134-138.
LING Gengqiang, MA Dongying, HE Ruixing, et al.
Influence of tumor microenvironment on vasculogenic
mimicry formation in glioma[J]. Chin Med Biotechnol,
2017, 12(2):134-138.
[13] 丁茜, 李振, 刘滨，等. 卡维地洛抑制血小板衍生因
子BB 诱导的人肝星状细胞活化和纤维化的作用机
制[J]. 临床肝胆病杂志, 2017, 33(3): 485-491.
DING Qian, LI Zhen, LIU Bin, et al. Inhibitory effect
of carvedilol on human hepatic stellate cell activation
and fibrosis induced by platelet-derived growth factor-
BB and related mechanisms of action[J]. J Clin Hepatol,
2017, 33(3): 485-491.
[14] 步玉辉, 史建红， 崔万鹏， 等. PDGF-BB 对SKBR-
3 乳腺癌细胞迁移、增殖的影响[J]. 山东医药，
2014, 54(14): 5-7.
BU Yuhui，SHI Jianhong, CUI Wanpeng. Effects of
PDGF-BB on migration and proliferation of SK-BR-3
mammary carcinoma cells[J]. Shangdong Medical Journal,
2014, 54(14): 5-7.
[15] 隆绍平, 邓世群, 赵世元. PTPN12 蛋白表达下调与
原发性肝细胞癌患者复发和预后关系研究[J]. 现代
检验医学杂志, 2018, 33(1):86-90.
LONG Shaoping, DENG Shiqun, ZHAO Shiyuan. Association
between downregulation of PTPN12 protein
and recurrence and prognosis in patients with primary
hepatocellular carcinoma[J]. J Mod Lab Med, 2018,
33(1):86-90.